Shenzhen Kangtai Biological Products
Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2020
AstraZeneca signs vaccine licensing deal with BioKangtai
AstraZeneca signed a licensing deal with BioKangtai to supply its AZD1222 COVID-19 vaccine candidate to China. The companies also said they would explore the possibility of producing the vaccine for other markets.